1 Study Coverage
    1.1 Human Alpha1-Proteinase Inhibitor Product Introduction
    1.2 Market by Type
        1.2.1 Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 0.5g
        1.2.3 1g
    1.3 Market by Application
        1.3.1 Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Human Alpha1-Proteinase Inhibitor Sales Estimates and Forecasts 2017-2028
    2.2 Global Human Alpha1-Proteinase Inhibitor Revenue Estimates and Forecasts 2017-2028
    2.3 Global Human Alpha1-Proteinase Inhibitor Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Human Alpha1-Proteinase Inhibitor Sales by Region
        2.4.1 Global Human Alpha1-Proteinase Inhibitor Sales by Region (2017-2022)
        2.4.2 Global Sales Human Alpha1-Proteinase Inhibitor by Region (2023-2028)
    2.5 Global Human Alpha1-Proteinase Inhibitor Revenue by Region
        2.5.1 Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2017-2022)
        2.5.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Human Alpha1-Proteinase Inhibitor Sales by Manufacturers
        3.1.1 Global Top Human Alpha1-Proteinase Inhibitor Manufacturers by Sales (2017-2022)
        3.1.2 Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Alpha1-Proteinase Inhibitor in 2021
    3.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Manufacturers
        3.2.1 Global Human Alpha1-Proteinase Inhibitor Revenue by Manufacturers (2017-2022)
        3.2.2 Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Human Alpha1-Proteinase Inhibitor Revenue in 2021
    3.3 Global Human Alpha1-Proteinase Inhibitor Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Human Alpha1-Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Human Alpha1-Proteinase Inhibitor Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Human Alpha1-Proteinase Inhibitor Sales by Type
        4.1.1 Global Human Alpha1-Proteinase Inhibitor Historical Sales by Type (2017-2022)
        4.1.2 Global Human Alpha1-Proteinase Inhibitor Forecasted Sales by Type (2023-2028)
        4.1.3 Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2017-2028)
    4.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Type
        4.2.1 Global Human Alpha1-Proteinase Inhibitor Historical Revenue by Type (2017-2022)
        4.2.2 Global Human Alpha1-Proteinase Inhibitor Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2017-2028)
    4.3 Global Human Alpha1-Proteinase Inhibitor Price by Type
        4.3.1 Global Human Alpha1-Proteinase Inhibitor Price by Type (2017-2022)
        4.3.2 Global Human Alpha1-Proteinase Inhibitor Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Human Alpha1-Proteinase Inhibitor Sales by Application
        5.1.1 Global Human Alpha1-Proteinase Inhibitor Historical Sales by Application (2017-2022)
        5.1.2 Global Human Alpha1-Proteinase Inhibitor Forecasted Sales by Application (2023-2028)
        5.1.3 Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2017-2028)
    5.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Application
        5.2.1 Global Human Alpha1-Proteinase Inhibitor Historical Revenue by Application (2017-2022)
        5.2.2 Global Human Alpha1-Proteinase Inhibitor Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2017-2028)
    5.3 Global Human Alpha1-Proteinase Inhibitor Price by Application
        5.3.1 Global Human Alpha1-Proteinase Inhibitor Price by Application (2017-2022)
        5.3.2 Global Human Alpha1-Proteinase Inhibitor Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Human Alpha1-Proteinase Inhibitor Market Size by Type
        6.1.1 North America Human Alpha1-Proteinase Inhibitor Sales by Type (2017-2028)
        6.1.2 North America Human Alpha1-Proteinase Inhibitor Revenue by Type (2017-2028)
    6.2 North America Human Alpha1-Proteinase Inhibitor Market Size by Application
        6.2.1 North America Human Alpha1-Proteinase Inhibitor Sales by Application (2017-2028)
        6.2.2 North America Human Alpha1-Proteinase Inhibitor Revenue by Application (2017-2028)
    6.3 North America Human Alpha1-Proteinase Inhibitor Market Size by Country
        6.3.1 North America Human Alpha1-Proteinase Inhibitor Sales by Country (2017-2028)
        6.3.2 North America Human Alpha1-Proteinase Inhibitor Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
        6.3.5 Mexico
7 Europe
    7.1 Europe Human Alpha1-Proteinase Inhibitor Market Size by Type
        7.1.1 Europe Human Alpha1-Proteinase Inhibitor Sales by Type (2017-2028)
        7.1.2 Europe Human Alpha1-Proteinase Inhibitor Revenue by Type (2017-2028)
    7.2 Europe Human Alpha1-Proteinase Inhibitor Market Size by Application
        7.2.1 Europe Human Alpha1-Proteinase Inhibitor Sales by Application (2017-2028)
        7.2.2 Europe Human Alpha1-Proteinase Inhibitor Revenue by Application (2017-2028)
    7.3 Europe Human Alpha1-Proteinase Inhibitor Market Size by Country
        7.3.1 Europe Human Alpha1-Proteinase Inhibitor Sales by Country (2017-2028)
        7.3.2 Europe Human Alpha1-Proteinase Inhibitor Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 UK
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Human Alpha1-Proteinase Inhibitor Market Size by Type
        8.1.1 Asia Pacific Human Alpha1-Proteinase Inhibitor Sales by Type (2017-2028)
        8.1.2 Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue by Type (2017-2028)
    8.2 Asia Pacific Human Alpha1-Proteinase Inhibitor Market Size by Application
        8.2.1 Asia Pacific Human Alpha1-Proteinase Inhibitor Sales by Application (2017-2028)
        8.2.2 Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue by Application (2017-2028)
    8.3 Asia Pacific Human Alpha1-Proteinase Inhibitor Market Size by Region
        8.3.1 Asia Pacific Human Alpha1-Proteinase Inhibitor Sales by Region (2017-2028)
        8.3.2 Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Human Alpha1-Proteinase Inhibitor Market Size by Type
        9.1.1 Latin America Human Alpha1-Proteinase Inhibitor Sales by Type (2017-2028)
        9.1.2 Latin America Human Alpha1-Proteinase Inhibitor Revenue by Type (2017-2028)
    9.2 Latin America Human Alpha1-Proteinase Inhibitor Market Size by Application
        9.2.1 Latin America Human Alpha1-Proteinase Inhibitor Sales by Application (2017-2028)
        9.2.2 Latin America Human Alpha1-Proteinase Inhibitor Revenue by Application (2017-2028)
    9.3 Latin America Human Alpha1-Proteinase Inhibitor Market Size by Country
        9.3.1 Latin America Human Alpha1-Proteinase Inhibitor Sales by Country (2017-2028)
        9.3.2 Latin America Human Alpha1-Proteinase Inhibitor Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Human Alpha1-Proteinase Inhibitor Market Size by Type
        10.1.1 Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue by Type (2017-2028)
    10.2 Middle East and Africa Human Alpha1-Proteinase Inhibitor Market Size by Application
        10.2.1 Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue by Application (2017-2028)
    10.3 Middle East and Africa Human Alpha1-Proteinase Inhibitor Market Size by Country
        10.3.1 Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Takeda
        11.1.1 Takeda Corporation Information
        11.1.2 Takeda Overview
        11.1.3 Takeda Human Alpha1-Proteinase Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Takeda Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Takeda Recent Developments
    11.2 Kamada
        11.2.1 Kamada Corporation Information
        11.2.2 Kamada Overview
        11.2.3 Kamada Human Alpha1-Proteinase Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Kamada Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Kamada Recent Developments
    11.3 Talecris Biotherapeutics
        11.3.1 Talecris Biotherapeutics Corporation Information
        11.3.2 Talecris Biotherapeutics Overview
        11.3.3 Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Talecris Biotherapeutics Recent Developments
    11.4 CSL Behring
        11.4.1 CSL Behring Corporation Information
        11.4.2 CSL Behring Overview
        11.4.3 CSL Behring Human Alpha1-Proteinase Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 CSL Behring Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 CSL Behring Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Human Alpha1-Proteinase Inhibitor Industry Chain Analysis
    12.2 Human Alpha1-Proteinase Inhibitor Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Human Alpha1-Proteinase Inhibitor Production Mode & Process
    12.4 Human Alpha1-Proteinase Inhibitor Sales and Marketing
        12.4.1 Human Alpha1-Proteinase Inhibitor Sales Channels
        12.4.2 Human Alpha1-Proteinase Inhibitor Distributors
    12.5 Human Alpha1-Proteinase Inhibitor Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Human Alpha1-Proteinase Inhibitor Industry Trends
    13.2 Human Alpha1-Proteinase Inhibitor Market Drivers
    13.3 Human Alpha1-Proteinase Inhibitor Market Challenges
    13.4 Human Alpha1-Proteinase Inhibitor Market Restraints
14 Key Findings in The Global Human Alpha1-Proteinase Inhibitor Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 0.5g
    Table 3. Major Manufacturers of 1g
    Table 4. Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Human Alpha1-Proteinase Inhibitor Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Human Alpha1-Proteinase Inhibitor Sales by Region (2017-2022) & (MT)
    Table 7. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2017-2022)
    Table 8. Global Human Alpha1-Proteinase Inhibitor Sales by Region (2023-2028) & (MT)
    Table 9. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2023-2028)
    Table 10. Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2017-2022)
    Table 12. Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2023-2028)
    Table 14. Global Human Alpha1-Proteinase Inhibitor Sales by Manufacturers (2017-2022) & (MT)
    Table 15. Global Human Alpha1-Proteinase Inhibitor Sales Share by Manufacturers (2017-2022)
    Table 16. Global Human Alpha1-Proteinase Inhibitor Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Manufacturers (2017-2022)
    Table 18. Human Alpha1-Proteinase Inhibitor Price by Manufacturers (2017-2022) &(USD/Kg)
    Table 19. Global Human Alpha1-Proteinase Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Human Alpha1-Proteinase Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Alpha1-Proteinase Inhibitor as of 2021)
    Table 21. Human Alpha1-Proteinase Inhibitor Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Human Alpha1-Proteinase Inhibitor Product Offered
    Table 23. Date of Manufacturers Enter into Human Alpha1-Proteinase Inhibitor Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Human Alpha1-Proteinase Inhibitor Sales by Type (2017-2022) & (MT)
    Table 26. Global Human Alpha1-Proteinase Inhibitor Sales by Type (2023-2028) & (MT)
    Table 27. Global Human Alpha1-Proteinase Inhibitor Sales Share by Type (2017-2022)
    Table 28. Global Human Alpha1-Proteinase Inhibitor Sales Share by Type (2023-2028)
    Table 29. Global Human Alpha1-Proteinase Inhibitor Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Human Alpha1-Proteinase Inhibitor Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Type (2017-2022)
    Table 32. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Type (2023-2028)
    Table 33. Human Alpha1-Proteinase Inhibitor Price by Type (2017-2022) & (USD/Kg)
    Table 34. Global Human Alpha1-Proteinase Inhibitor Price Forecast by Type (2023-2028) & (USD/Kg)
    Table 35. Global Human Alpha1-Proteinase Inhibitor Sales by Application (2017-2022) & (MT)
    Table 36. Global Human Alpha1-Proteinase Inhibitor Sales by Application (2023-2028) & (MT)
    Table 37. Global Human Alpha1-Proteinase Inhibitor Sales Share by Application (2017-2022)
    Table 38. Global Human Alpha1-Proteinase Inhibitor Sales Share by Application (2023-2028)
    Table 39. Global Human Alpha1-Proteinase Inhibitor Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Human Alpha1-Proteinase Inhibitor Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Application (2017-2022)
    Table 42. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Application (2023-2028)
    Table 43. Human Alpha1-Proteinase Inhibitor Price by Application (2017-2022) & (USD/Kg)
    Table 44. Global Human Alpha1-Proteinase Inhibitor Price Forecast by Application (2023-2028) & (USD/Kg)
    Table 45. North America Human Alpha1-Proteinase Inhibitor Sales by Type (2017-2022) & (MT)
    Table 46. North America Human Alpha1-Proteinase Inhibitor Sales by Type (2023-2028) & (MT)
    Table 47. North America Human Alpha1-Proteinase Inhibitor Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Human Alpha1-Proteinase Inhibitor Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Human Alpha1-Proteinase Inhibitor Sales by Application (2017-2022) & (MT)
    Table 50. North America Human Alpha1-Proteinase Inhibitor Sales by Application (2023-2028) & (MT)
    Table 51. North America Human Alpha1-Proteinase Inhibitor Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Human Alpha1-Proteinase Inhibitor Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Human Alpha1-Proteinase Inhibitor Sales by Country (2017-2022) & (MT)
    Table 54. North America Human Alpha1-Proteinase Inhibitor Sales by Country (2023-2028) & (MT)
    Table 55. North America Human Alpha1-Proteinase Inhibitor Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Human Alpha1-Proteinase Inhibitor Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Human Alpha1-Proteinase Inhibitor Sales by Type (2017-2022) & (MT)
    Table 58. Europe Human Alpha1-Proteinase Inhibitor Sales by Type (2023-2028) & (MT)
    Table 59. Europe Human Alpha1-Proteinase Inhibitor Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Human Alpha1-Proteinase Inhibitor Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Human Alpha1-Proteinase Inhibitor Sales by Application (2017-2022) & (MT)
    Table 62. Europe Human Alpha1-Proteinase Inhibitor Sales by Application (2023-2028) & (MT)
    Table 63. Europe Human Alpha1-Proteinase Inhibitor Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Human Alpha1-Proteinase Inhibitor Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Human Alpha1-Proteinase Inhibitor Sales by Country (2017-2022) & (MT)
    Table 66. Europe Human Alpha1-Proteinase Inhibitor Sales by Country (2023-2028) & (MT)
    Table 67. Europe Human Alpha1-Proteinase Inhibitor Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Human Alpha1-Proteinase Inhibitor Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Human Alpha1-Proteinase Inhibitor Sales by Type (2017-2022) & (MT)
    Table 70. Asia Pacific Human Alpha1-Proteinase Inhibitor Sales by Type (2023-2028) & (MT)
    Table 71. Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Human Alpha1-Proteinase Inhibitor Sales by Application (2017-2022) & (MT)
    Table 74. Asia Pacific Human Alpha1-Proteinase Inhibitor Sales by Application (2023-2028) & (MT)
    Table 75. Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Human Alpha1-Proteinase Inhibitor Sales by Region (2017-2022) & (MT)
    Table 78. Asia Pacific Human Alpha1-Proteinase Inhibitor Sales by Region (2023-2028) & (MT)
    Table 79. Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Human Alpha1-Proteinase Inhibitor Sales by Type (2017-2022) & (MT)
    Table 82. Latin America Human Alpha1-Proteinase Inhibitor Sales by Type (2023-2028) & (MT)
    Table 83. Latin America Human Alpha1-Proteinase Inhibitor Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Human Alpha1-Proteinase Inhibitor Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Human Alpha1-Proteinase Inhibitor Sales by Application (2017-2022) & (MT)
    Table 86. Latin America Human Alpha1-Proteinase Inhibitor Sales by Application (2023-2028) & (MT)
    Table 87. Latin America Human Alpha1-Proteinase Inhibitor Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Human Alpha1-Proteinase Inhibitor Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Human Alpha1-Proteinase Inhibitor Sales by Country (2017-2022) & (MT)
    Table 90. Latin America Human Alpha1-Proteinase Inhibitor Sales by Country (2023-2028) & (MT)
    Table 91. Latin America Human Alpha1-Proteinase Inhibitor Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Human Alpha1-Proteinase Inhibitor Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales by Type (2017-2022) & (MT)
    Table 94. Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales by Type (2023-2028) & (MT)
    Table 95. Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales by Application (2017-2022) & (MT)
    Table 98. Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales by Application (2023-2028) & (MT)
    Table 99. Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales by Country (2017-2022) & (MT)
    Table 102. Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales by Country (2023-2028) & (MT)
    Table 103. Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Takeda Corporation Information
    Table 106. Takeda Description and Major Businesses
    Table 107. Takeda Human Alpha1-Proteinase Inhibitor Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 108. Takeda Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Takeda Recent Developments
    Table 110. Kamada Corporation Information
    Table 111. Kamada Description and Major Businesses
    Table 112. Kamada Human Alpha1-Proteinase Inhibitor Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 113. Kamada Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Kamada Recent Developments
    Table 115. Talecris Biotherapeutics Corporation Information
    Table 116. Talecris Biotherapeutics Description and Major Businesses
    Table 117. Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 118. Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Talecris Biotherapeutics Recent Developments
    Table 120. CSL Behring Corporation Information
    Table 121. CSL Behring Description and Major Businesses
    Table 122. CSL Behring Human Alpha1-Proteinase Inhibitor Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 123. CSL Behring Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. CSL Behring Recent Developments
    Table 125. Key Raw Materials Lists
    Table 126. Raw Materials Key Suppliers Lists
    Table 127. Human Alpha1-Proteinase Inhibitor Distributors List
    Table 128. Human Alpha1-Proteinase Inhibitor Customers List
    Table 129. Human Alpha1-Proteinase Inhibitor Market Trends
    Table 130. Human Alpha1-Proteinase Inhibitor Market Drivers
    Table 131. Human Alpha1-Proteinase Inhibitor Market Challenges
    Table 132. Human Alpha1-Proteinase Inhibitor Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Alpha1-Proteinase Inhibitor Product Picture
    Figure 3. Global Human Alpha1-Proteinase Inhibitor Market Share by Type in 2021 & 2028
    Figure 3. 0.5g Product Picture
    Figure 4. 1g Product Picture
    Figure 5. Global Human Alpha1-Proteinase Inhibitor Market Share by Application in 2021 & 2028
    Figure 6. Hospital
    Figure 7. Pharmacy
    Figure 8. Human Alpha1-Proteinase Inhibitor Report Years Considered
    Figure 9. Global Human Alpha1-Proteinase Inhibitor Sales 2017-2028 (MT)
    Figure 10. Global Human Alpha1-Proteinase Inhibitor Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Human Alpha1-Proteinase Inhibitor Revenue 2017-2028 (US$ Million)
    Figure 12. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2017-2022)
    Figure 14. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2023-2028)
    Figure 15. North America Human Alpha1-Proteinase Inhibitor Sales YoY (2017-2028) & (MT)
    Figure 16. North America Human Alpha1-Proteinase Inhibitor Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Human Alpha1-Proteinase Inhibitor Sales YoY (2017-2028) & (MT)
    Figure 18. Europe Human Alpha1-Proteinase Inhibitor Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Human Alpha1-Proteinase Inhibitor Sales YoY (2017-2028) & (MT)
    Figure 20. Asia-Pacific Human Alpha1-Proteinase Inhibitor Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Human Alpha1-Proteinase Inhibitor Sales YoY (2017-2028) & (MT)
    Figure 22. Latin America Human Alpha1-Proteinase Inhibitor Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales YoY (2017-2028) & (MT)
    Figure 24. Middle East & Africa Human Alpha1-Proteinase Inhibitor Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Human Alpha1-Proteinase Inhibitor Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Human Alpha1-Proteinase Inhibitor in the World: Market Share by Human Alpha1-Proteinase Inhibitor Revenue in 2021
    Figure 27. Global Human Alpha1-Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2017-2028)
    Figure 29. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2017-2028)
    Figure 30. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2017-2028)
    Figure 31. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2017-2028)
    Figure 32. North America Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2017-2028)
    Figure 33. North America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2017-2028)
    Figure 34. North America Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2017-2028)
    Figure 35. North America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2017-2028)
    Figure 36. North America Human Alpha1-Proteinase Inhibitor Sales Share by Country (2017-2028)
    Figure 37. North America Human Alpha1-Proteinase Inhibitor Revenue Share by Country (2017-2028)
    Figure 38. United States Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 40. Mexico Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2017-2028)
    Figure 42. Europe Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2017-2028)
    Figure 44. Europe Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Human Alpha1-Proteinase Inhibitor Sales Share by Country (2017-2028)
    Figure 46. Europe Human Alpha1-Proteinase Inhibitor Revenue Share by Country (2017-2028)
    Figure 47. Germany Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 48. France Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 49. UK Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Human Alpha1-Proteinase Inhibitor Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue Share by Region (2017-2028)
    Figure 58. China Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 61. India Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Human Alpha1-Proteinase Inhibitor Sales Share by Country (2017-2028)
    Figure 72. Latin America Human Alpha1-Proteinase Inhibitor Revenue Share by Country (2017-2028)
    Figure 73. Mexico Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue Share by Country (2017-2028)
    Figure 82. Turkey Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Human Alpha1-Proteinase Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 85. Human Alpha1-Proteinase Inhibitor Value Chain
    Figure 86. Human Alpha1-Proteinase Inhibitor Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed